TOPICYCLINE Drug Patent Profile
When do Topicycline patents expire, and what generic alternatives are available?
Topicycline is a drug marketed by Shire and is included in one NDA.
The generic ingredient in TOPICYCLINE is tetracycline hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Topicycline
A generic version of TOPICYCLINE was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TOPICYCLINE?
- What are the global sales for TOPICYCLINE?
- What is Average Wholesale Price for TOPICYCLINE?
Summary for TOPICYCLINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Patent Applications: | 6,867 |
| DailyMed Link: | TOPICYCLINE at DailyMed |
US Patents and Regulatory Information for TOPICYCLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shire | TOPICYCLINE | tetracycline hydrochloride | FOR SOLUTION;TOPICAL | 050493-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
